| 来源类型 | Discussion paper |
| 规范类型 | 论文 |
| 来源ID | DP15544 |
| DP15544 Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool | |
| Alberto Galasso; Mark Schankerman | |
| 发表日期 | 2020-12-11 |
| 出版年 | 2020 |
| 语种 | 英语 |
| 摘要 | We study the effects of a patent pool on the licensing and adoption of life-saving drugs in low- and middle-income countries. Using data on licensing and sales for HIV, hepatitis C and tuberculosis drugs, we show that there is an immediate and large increase in licensing by generic firms when a patent is included in the Medicines Patent Pool (MPP). This finding is robust to identification strategies to deal with endogeneity of MPP patents and countries. The impact of the MPP is especially large for small, non-Sub-Saharan countries. The impact on actual entry and sales, however, is much smaller than on licensing, which is due to geographic bundling of licenses by the MPP. More broadly, the paper highlights the potential of pools in promoting technology diffusion of biomedical innovation. |
| 主题 | Development Economics ; Industrial Organization |
| 关键词 | Patents Licensing Patent pool Pharmaceuticals Hiv Public health Developing countries |
| URL | https://cepr.org/publications/dp15544 |
| 来源智库 | Centre for Economic Policy Research (United Kingdom) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/544547 |
| 推荐引用方式 GB/T 7714 | Alberto Galasso,Mark Schankerman. DP15544 Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool. 2020. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
